AzTrials
AzTrials

Dementia of Alzheimer TypeNCT05923307

Multifactorial Approach to Dementia, Multicentric Study

An observational study of Dementia of Alzheimer Type and Dementia Frontotemporal, run by Daniel Serrani Azcurra at 1 site in Argentina.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The goal of this observational study is to assess the role of narcisistic personality disorder and life stressful events in conversion rate to dementia, using a three tier approach along three research lines employing subjects with dementia in retrospective assessment, and normal subjects no yet developing demetia in… Read more about this study

Who is it for?
Ages 45 to 80 yearsHealthy volunteers can take part
How many people
450 participants
Where
1 siteArgentina
Study dates
20 May 2023to 20 Sep 2024
How long will I take part?
1 Year
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 45 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: individuals eligible to participate were diagnosed with dementia, or had inconclusive results living at the community or residential institutions invited to attend a follow-up, cognitively healthy or minimally impaired, or had mild cognitive impairment (MCI), or dementia

Who may be able to join

  • research line 3
  • healthy subjects over 50 years of age.
  • diagnosis of dementia should be made according to DSM V criteria.
  • Diagnoses made by operationalised criteria for dementia

Who cannot join

  • Participants excluded if declined participation, died or withdrew from the study
  • unable to perform the assessments due to other co-morbid conditions
  • were too visually impaired to complete cognitive assessments.
  • in research lines 1 and 2 inclusion criteria subjects with confirmed diagnosis of dementia
  • putative narcisistic personality disorder
  • no age limit

Trial locations and contacts

1 site in 1 country.

Argentina1 site, 1 recruiting
  • universidad Atlantida

    Buenos Aires, Outside U.S. and Canada, 1405

    daniel joge serrani, MD, 01168087072, danielserraniazcurra@gmail.com

    daniel jorge serrani, MD, +541168087072, danielserraniazcurra@gmail.com

    Recruiting

Other trials in Argentina

About this study

Official title: Multifactorial Approach to Dementia. Multicentric Study

The goal of this observational study is to assess the role of narcisistic personality disorder and life stressful events in conversion rate to dementia, using a three tier approach along three research lines employing subjects with dementia in retrospective assessment, and normal subjects no yet developing demetia in prospective follow up. The main question[s] it aims to answer are:

  • narcisistic personality disorder as risk factor for conversion to dementia
  • life stressful events as risk factor for conversion to dementia Participants will be assessed with a complete neurocognitive battery, brain images studies, laboratory analysis, and sociodemographic profile, including depression and comorbidities.
Read the detailed description

Previous studies have identified multiple risk factors for dementia in a variety of settings. However personality traits have received less attention as a contributing or mediating factor. The identification of potentially modifiable risk factors has been critical in the development of effective multifactorial intervention programmes for people at risk of dementia. Studies that examined the role of personality traits as risk factor for dementia recruited participants with mild cognitive impairment or mild to moderate dementia living in institutional or community settings. In this 3 tiered study, 3 lines of research will be pursued. In lines 1 and 2 retrospective analysis of patients with dementia will be performed searching for the mediating or predisposing role of narcissistic personality disorder as a risk factor for the development of dementia. in the 3rd line of research normal participants will complete a multifactorial baseline assessment of putative predictors of mild cognitive impairment or dementia and then will complete prospective cognitive, affective and personality diaries for a period of 12 months, in order to detect association of personality traits to dementia conversion.

Methods Ethics statement This study will be submitted to Ethics Committee of INICIEN Research Authority, and participants will be requested to give written informed consent in accordance with the declaration of Helsinki.

Design Longitudinal prospective and retrospective cohort study. Participant recruitment 3 lines of research. In line 1 and 2 patients with dementia will be assessed in a retrospective approach and in the line 3 healthy cases without cognitive impairment will be recruited to determine if narcisistic personality play a role in the risk of dementia onset (AD, frontotemporal dementia). Patients files and subjects will be recruited from multicenter Neurology, Old Age Psychiatry and Geriatric Medical secondary care outpatient clinics. Cases should be referred to these clinics for assessment, diagnosis and management by their primary care physician, or referred to a Psychiatrist by their clinical physician.

Inclusion and exclusion criteria All participants should be over 50 years of age in research line 1, and no age limit will be assumed for cases in reesarch lines 1 and 2. All diagnoses of dementia will be made according to DSM V criteria. Significant medical causes of dementia should be excluded during diagnostic investigations. Diagnoses will be made by operationalised criteria for dementia validated against neuropathological diagnosis Participants were excluded if they declined participation, died or withdrew from the study before commencing follow up period, unable to perform the assessments due to other co-morbid conditions, or were too visually impaired to complete cognitive assessments. Baseline Clinical Assessment All participants received a detailed baseline assessment to quantify putative risk factors for dementia. The factors included were selected on the basis of their previous identification as risk factors in more than one high quality study in older people, and/or their relevance to clinical features of dementia postulated to be causative of neurocognive disorder conversion.

Assessments included medical history (residence, history of life stressful events, affective state, sociodemographic factors). Objective assessments included the cognitive battery, personality assessment with narcisistic personality disorder, Yesavage depression scale. Participants were assessed at baseline and during follow up period of one year.

Dementia specific scales were used to assess specific staging level and dementia specific type, depression, and behavioural and psychological symptoms of dementia.

Outcome Measures The primary outcome measure will be dementia conversion occurring during the 12 month follow up period. Secondary outcome measures will be proportional hazard ratios for time to dementia conversion, according to diagnosis and status of personality disorder narcisistic type as putative clinical predictor. If the participants did not show off at previously assigned points, they will be reminded by telephone after 2 weeks. The caregiver will be asked to assist in the completion of diaries when dementia is present.

Statistics Differences in baseline characteristics across groups will be compared using Fisher's Exact test for categorical data, ANOVA for normally distributed data and Kruskal-Wallis for non-normally distributed data. Differences between individual groups will be compared using the Chi squared test for categorical data, Student's t test for normally distributed data and Mann-Whitney U test for non-normally distributed data.

In case of censoring of data from some participants (as a result of death or withdrawal from the study), Cox regression (adjusted for age and sex) will be used to obtain a proportional hazard ratio for personality disorder as risk factor to dementia conversion. Loglinear Poisson regression models (adjusted for age and sex) will be used to obtain an incidence density ratio for dementia and its subtypes in comparison with healthy controls. without personality disorders In order to examine the associations between exposure to narcisitic personality disorder as risk factors for dementia conversion in those participants with dementia, Cox regression will be used to obtain univariate proportional hazard ratios for each risk factor, adjusted for age and sex, using time to the occurrence of at least mild cognitive impairment as the dependent variable. Hazard ratios will be given according to presence or absence of the risk factor, or per point on quantitative scales as appropriate. Analyses will be performed initially for all participants with or without dementia, and then repeated stratified by diagnosis.

Following identification in univariate models, significant and potentially modifiable risk factors will be entered into a multivariate forward stepwise Cox regression model, p 0.05 for entry, p 0.1 for removal. Age and sex will be included even if not significant. Where similar clinical features coould be described by more than one significant risk factor the factor with the higher level of significance in univariate analyses will be entered into multivariate analyses, in order to avoid co-aggregation of predictors.

Medical subject headings
Pick Disease of the Brain, Narcissistic Personality Disorder, Depression

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. new onset of dementia during the follow-up period

    dementia diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders V, considered affected by dementia when agreement on this diagnosis was reached between a psychologist and a geriatrician. If the physicians failed to agree, the diagnosis had to be confirmed by a second geriatrician.

    Measured: 1 year

Secondary outcomes (1)
  1. univariate proportional hazard ratios for narcissistic personality as risk factor, adjusted for age and sex

    Hazard ratios are given according to presence or absence of the risk factor, or per point on quantitative scales as appropriate.

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Jun 2023
  2. Study start20 May 2023
  3. Primary completion20 Apr 2024 (estimated)
  4. Study completion20 Sep 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
450 participants (estimated)
Target duration
1 Year
IDs, dates and publications
ClinicalTrials.gov ID
NCT05923307
Sponsor's protocol ID
01569
Status last verified
Jul 2023
First submitted
19 Jun 2023
Last updated
6 Jul 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Fiest KM, Jette N, Roberts JI, Maxwell CJ, Smith EE, Black SE, Blaikie L, Cohen A, Day L, Holroyd-Leduc J, Kirk A, Pearson D, Pringsheim T, Venegas-Torres A, Hogan DB. The Prevalence and Incidence of Dementia: a Systematic Review and Meta-analysis. Can J Neurol Sci. 2016 Apr;43 Suppl 1:S3-S50. doi: 10.1017/cjn.2016.18.

    PubMed 27307127
  • Ganguli M, Dodge HH, Chen P, Belle S, DeKosky ST. Ten-year incidence of dementia in a rural elderly US community population: the MoVIES Project. Neurology. 2000 Mar 14;54(5):1109-16. doi: 10.1212/wnl.54.5.1109.

    PubMed 10720283
  • serrani daniel Narcissism Vulnerability as Risk Factor for Alzheimer´s Disease- A Prospective Study Austin J Clin Neurol 2015;2(7): 1057.

  • Chatterjee A, Strauss ME, Smyth KA, Whitehouse PJ. Personality changes in Alzheimer's disease. Arch Neurol. 1992 May;49(5):486-91. doi: 10.1001/archneur.1992.00530290070014.

    PubMed 1580810
  • Wilson RS, Schneider JA, Arnold SE, Bienias JL, Bennett DA. Conscientiousness and the incidence of Alzheimer disease and mild cognitive impairment. Arch Gen Psychiatry. 2007 Oct;64(10):1204-12. doi: 10.1001/archpsyc.64.10.1204.

    PubMed 17909133

Questions about this trial

What is this clinical trial studying?

An observational study of Dementia of Alzheimer Type and Dementia Frontotemporal, run by Daniel Serrani Azcurra at 1 site in Argentina.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 6 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Argentina. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

new onset of dementia during the follow-up period (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05923307, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jul 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in